Nightingale Health Oyj (FRA:7XE)

Nightingale Health Oyj Statistics

Total Valuation

FRA:7XE has a market cap or net worth of EUR 133.82 million. The enterprise value is 86.18 million.

Market Cap	133.82M
Enterprise Value	86.18M

Important Dates

The next estimated earnings date is Thursday, March 5, 2026.

Earnings Date	Mar 5, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	40.54M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	-1.88%
Owned by Insiders (%)	30.03%
Owned by Institutions (%)	5.59%
Float	34.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	28.52
PB Ratio	2.02
P/TBV Ratio	2.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.67
EV / Sales	18.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-6.96

Financial Position

The company has a current ratio of 8.80, with a Debt / Equity ratio of 0.05.

Current Ratio	8.80
Quick Ratio	8.45
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	-0.29
Interest Coverage	-1,761.82

Financial Efficiency

Return on equity (ROE) is -24.77% and return on invested capital (ROIC) is -15.60%.

Return on Equity (ROE)	-24.77%
Return on Assets (ROA)	-14.65%
Return on Invested Capital (ROIC)	-15.60%
Return on Capital Employed (ROCE)	-28.37%
Revenue Per Employee	46,930
Profits Per Employee	-184,610
Employee Count	100
Asset Turnover	0.06
Inventory Turnover	0.94

Taxes

In the past 12 months, FRA:7XE has paid 53,000 in taxes.

Income Tax	53,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -27.97% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-27.97%
50-Day Moving Average	2.23
200-Day Moving Average	2.52
Relative Strength Index (RSI)	43.23
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:7XE had revenue of EUR 4.69 million and -18.46 million in losses. Loss per share was -0.31.

Revenue	4.69M
Gross Profit	3.54M
Operating Income	-19.38M
Pretax Income	-18.41M
Net Income	-18.46M
EBITDA	-14.50M
EBIT	-19.38M
Loss Per Share	-0.31

Balance Sheet

The company has 51.21 million in cash and 3.57 million in debt, giving a net cash position of 47.64 million.

Cash & Cash Equivalents	51.21M
Total Debt	3.57M
Net Cash	47.64M
Net Cash Per Share	n/a
Equity (Book Value)	66.17M
Book Value Per Share	1.10
Working Capital	48.41M

Cash Flow

In the last 12 months, operating cash flow was -10.11 million and capital expenditures -2.28 million, giving a free cash flow of -12.39 million.

Operating Cash Flow	-10.11M
Capital Expenditures	-2.28M
Free Cash Flow	-12.39M
FCF Per Share	n/a

Margins

Gross Margin	75.39%
Operating Margin	-412.96%
Pretax Margin	-392.24%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:7XE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.01%
Shareholder Yield	-0.01%
Earnings Yield	-13.80%
FCF Yield	-9.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:7XE has an Altman Z-Score of 11.05 and a Piotroski F-Score of 3.

Altman Z-Score	11.05
Piotroski F-Score	3